Screener
Monopar Therapeutics MNPR EPS (Diluted)
Discontinued — last reported Q1 '22
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Monopar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareBasicAndDiluted.
The source filing: Monopar Therapeutics’s 10-Q, filed May 12, 2022. Open the filing →
- Filed
- May 12, 2022, 9:41 AM EDT
- Fiscal quarter
- Q1 FY2022
- Calendar quarter
- Q1 2022
- Accession
- 0001654954-22-006507
FAQ
- What is Monopar Therapeutics's EPS (diluted)?
- Monopar Therapeutics (MNPR) reported EPS (diluted) of -$0.19 in Q1 2022.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Monopar Therapeutics's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude